SCHEMBL3846917

SCHEMBL3846917

CS(=O)(=O)OC1CC(C(N)=O)N(C(=O)O)C1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.41
ANPEP P15144 1/20 0.41
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1251163 0.87 ATM (0.42) MMP2ANPEPATM
SCHEMBL6917231 0.87 ATM (0.42) MMP2ANPEPATM
SCHEMBL1251161 0.87 ATM (0.42) MMP2ANPEPATM
SCHEMBL21682443 0.87 ATM (0.42) MMP2ANPEPATM
SCHEMBL1251167 0.87 ATM (0.42) MMP2ANPEPATM
SCHEMBL3476452 0.83 MMP2 (0.53) MMP2ANPEP
SCHEMBL7946508 0.82 MMP2 (0.37) MMP2ANPEP
SCHEMBL1155188 0.81 MMP2 (0.38) MMP2ANPEP
SCHEMBL1154446 0.81 MMP2 (0.38) MMP2ANPEP
SCHEMBL12469748 0.80 MMP2 (0.33) MMP2ANPEPATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035395-A2 NOVEL PROCESSES FOR THE PREPARATION OF DPP IV INHIBITORS Glenmark Pharmaceuticals S.A. (CH) 2009-03-18 EP disclosed
WO-2008001195-A2 NOVEL PROCESSES FOR THE PREPARATION OF DPP IV INHIBITORS GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-03 WO disclosed